Skip to main content

Surv Biopharma

Kagoshima, Japan

Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.

$9.7M raised
Nov 2025
Series B

Top Investors

Keio Innovation InitiativeNippon Venture CapitalDCI PartnersHigin CapitalQB Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Surv Biopharma

How much funding has Surv Biopharma raised?
Surv Biopharma has raised $9.7M in total funding. The most recent round was Series B. The last funding was announced in November 2025.
Who are Surv Biopharma's investors?
Surv Biopharma's investors include Keio Innovation Initiative, Nippon Venture Capital, DCI Partners, Higin Capital, QB Capital.
Where is Surv Biopharma headquartered?
Surv Biopharma is headquartered in Kagoshima, Japan.
What does Surv Biopharma do?
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
What stage is Surv Biopharma at?
Surv Biopharma is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Surv Biopharma — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/surv-biopharma. Accessed June 17, 2026.
APA
VCBacked. (2025). Surv Biopharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/surv-biopharma
Wikipedia (cite web)
{{cite web |title=Surv Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/surv-biopharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .